Pfizer Inc
XBER:PFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pfizer Inc
XBER:PFE
|
US |
|
Young & Co's Brewery PLC
F:YBY
|
UK |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
Cigna Corp
NYSE:CI
|
US |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
U
|
US Foods Holding Corp
F:UFH
|
US |
|
BlackRock Inc
MIL:1BLK
|
US |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
Wall St Price Targets
PFE Price Targets Summary
Pfizer Inc
According to Wall Street analysts, the average 1-year price target for
PFE is 24.43 EUR with a low forecast of 20.04 EUR and a high forecast of 31.25 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PFE's stock price target?
Price Target
24.43
EUR
According to Wall Street analysts, the average 1-year price target for
PFE is 24.43 EUR with a low forecast of 20.04 EUR and a high forecast of 31.25 EUR.
What is the Revenue forecast for Pfizer Inc?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is -1%.
What is the Operating Income forecast for Pfizer Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is -2%.
What is the Net Income forecast for Pfizer Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 8 years is 9%.